comparemela.com

Bright Path Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covira Builds Team, Closes First Dilutive Funding, Establishes Key Partnerships, and Prepares for Next Round of Funding

Players In The Pharmaceutical API Manufacturing Market Are Developing AI-Based Platforms For The Manufacturing Of APIs

The Business Research Company: Players In The Pharmaceutical API Manufacturing Market Are Developing AI-Based Platforms For The Manufacturing Of APIs

Rupus Global Limited to make inroads in Africa UAE to launch about 50 products in next 12 months, plans to make foray into US Market

Rupus Global Limited to make inroads in Africa & UAE to launch about 50 products in next 12 months, plans to make foray into US Market

California [US], May 10 (ANI/NewsVoir): Headquartered at Hong Kong, Rupus Global Limited (rupusglobal.com), one of the fastest growing pharmaceutical company with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and manufacturing services (CRAMS) in key segments such as Anti-Inflammatory, Anti-Protozoal, Anti-Diabetic, Vitamins, Anti-Malarial, Anti Cancer has set out an ambitious goal to boost its revenue for 225 Million USD by 2023-24.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.